Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04418167
Title JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors JS InnoPharm, LLC
Indications

lung non-small cell carcinoma

melanoma

Advanced Solid Tumor

Therapies

JSI-1187

Dabrafenib + JSI-1187

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Cancer Center Not yet recruiting Phoenix Arizona 85054 United States Details
University of Arizona Comprehensive Cancer Center Recruiting Tucson Arizona 85724 United States Details
University of California Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco California 94158 United States Details
Mayo Clinic Cancer Center Not yet recruiting Jacksonville Florida 32224 United States Details
Massachusetts General Hospital Cancer Center Recruiting Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute Recruiting Boston Massachusetts 02215 United States Details
Mayo Clinic Cancer Center Not yet recruiting Rochester Minnesota 55905 United States Details
University of Texas M.D. Anderson Cancer Center Active, not recruiting Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field